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Purpose: To validate a recently described animal model of abdominal aortic aneurysm
(AAA) and to assess a new macroporous polyester–covered stent for endovascular AAA
exclusion.
Methods: Twenty adult sheep had AAAs surgically created by replacing a segment of the
infrarenal aorta with an autologous jugular venous graft. Three months later, surviving
animals underwent percutaneous implantation of macroporous polyester–covered nitinol
stents; 3 animals with untreated AAAs served as controls. Follow-up surveillance included
spiral computed tomography at 1 month and digital subtraction angiography at 3 and 6
months. Endografted animals were sacrificed at 1, 3, and 6 months after implantation;
specimens from all animals were examined grossly and microscopically.
Results: Seven (35%) animals died within 24 hours of causes related to the technique; 1
animal developed paraplegia and was sacrificed on day 1. Three (25%) animals died of
spontaneous aneurysm rupture at ,10 days, and 6 received the stent-graft at 3 months.
The macroporous cover did not prevent continued perfusion of the sac early after stent-
graft deployment, but all aneurysms were excluded on the 1-month CT.
Conclusions: Spontaneous AAA rupture occurred earlier and was not as frequent as pre-
viously described for this model. Implantation of the covered stent was feasible, but an-
eurysm exclusion was not immediate.
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Despite growing knowledge in both the clini-
cal and experimental fields, several questions
remain unresolved about the endovascular
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treatment of abdominal aortic aneurysms
(AAA), notably the long-term consequences
of stent-grafts and the management of peri-
graft leaks. These doubts have prompted the
completion of experimental trials and feasi-
bility studies before new devices are used in
clinical practice.
The purpose of this study was twofold: (1)
to validate a previously described1 animal
model that creates an aneurysm by replacing
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Figure 1lOperative view of a venous segmental
AAA.
a segment of the infrarenal aorta with an au-
tologous internal jugular vein graft and (2) to
assess a new macroporous polyester–cov-
ered stent for endovascular AAA repair.
METHODS
We created AAAs in 20 male adult sheep (age
range 1–2 years) that were of the same breed
and weighed between 35 and 45 kg. The ani-
mals were maintained on a regular diet and
were cared for according to regulations of the
European Community on animal research.2
Three animals were assigned to the control
group, and the remainder were to receive an
experimental covered stent 3 months after
AAA creation. These stent-grafted animals
were to be sacrificed after implantation peri-
ods of 1, 3, or 6 months (4, 6, or 9 months
after AAA creation).
Aneurysm Creation
After a 24-hour fast and intravenous seda-
tion with acepromazine acetate (1 mL/10 kg),
the animals were intubated and placed under
general anesthesia using a mixture of thio-
barbital (125 mg/kg), bromochlorofluoroetha-
ne (2%), and oxygen (FiO2 5 60%).
Each animal was placed supine, and after
local shaving and disinfection, a 5- to 7-F in-
troducer was placed percutaneously in the
femoral artery. An aortogram was obtained.
After turning the animal on its right side, ster-
ile preparation and draping were repeated in
the cervical and abdominal regions. Through
a left lateral cervicotomy, the ipsilateral inter-
nal jugular vein was dissected and its branch-
es were ligated. A 40- to 50-mm-long segment
of this vein was removed and stored in hep-
arinized saline.
A left retroperitoneal approach to the aorta
was made through a lateral skin incision. Af-
ter dissection that spared the lumbar arteries
and systemic heparinization (50 U/kg), the
aorta was clamped, transected, and a 1-mm
circular segment of the aortic wall was re-
moved for analysis. A medullary protection
solution containing 12,500 units of heparin
and 7.5 g of N-methyl-thiourea (NMTU) per 1
liter of cold (48C) chlorinated saline was in-
fused intra-arterially to avoid paraplegia sec-
ondary to prolonged aortic clamping. (NMTU
protects against the effects of cellular ische-
mia by inhibiting free oxygen radicals, which
reduces reperfusion injury. Its liposolubility
and low molecular weight allow easy penetra-
tion into the central nervous system.) The so-
lution was infused via the sheath into the dis-
tal aorta (i.e., downstream of the distal aortic
clamp) at a flow rate of 100 mL/min through-
out aortic clamping (total volume 2L). As fa-
miliarity with the technique was gained, the
aortic clamping time was shortened, obviat-
ing the need for medullary protection in the
last 6 sheep.
The harvested venous segment was anas-
tomosed end-to-end with double rows of run-
ning 6–0 polypropylene sutures (Fig. 1). After
unclamping, hemostasis was checked. Both
proximal and distal aortic suture levels were
marked with either surgical clips or a radi-
opaque cerclage. The retroperitoneum was
closed in layers without drainage. Aortogra-
phy was performed in the operating room at
the end of the procedure (Fig. 2). Periopera-
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Figure 2lDigital subtraction arteriogram of a sur-
gically created AAA. Note the upper and lower me-
tallic cerclage.
tive antibiotic therapy was administered intra-
venously using 1.5 g cefuroxime. Extubation
was completed within 2 hours, and the ani-
mals were monitored under close supervision
for 24 to 48 hours in an isolated room.
Covered Stent Design and Implantation
The covered stent was made from a 12- 3
80-mm self-expanding metallic stent (Mem-
otherm, Angiomed-Bard, Karlsruhe, Germa-
ny) covered on the outside by a 60-mm-long
knitted macroporous polyester tube, which
left a 1-cm portion of the stent uncovered at
each end. The polyester material, which was
sutured to the stent, was made of 2 different
diameter threads (‘‘micromesh’’), which ren-
dered the material macroporous (exact poros-
ity undisclosed by the manufacturer owing to
a pending patent). The covered stent was
compressed on a carrier catheter, which was
inserted into a 70-cm-long, 10-F sheath (deliv-
ery system).
Stent-graft implantation was performed in
a digital angiography suite (DRS, General
Electrics Medical Systems) with the animal ly-
ing supine and anesthetized as described
above. A graduated ruler was placed on the
angiographic table. Percutaneous femoral ar-
tery access was obtained, and an 11-F intro-
ducer was inserted over a 180-cm-long, 0.035-
inch superstiff Amplatz guidewire (Boston
Scientific/Medi-tech, Natick, MA, USA). A cal-
ibrated pigtail catheter was passed through a
6-F introducer in the contralateral femoral ar-
tery for contrast injection. No heparin was
given during the procedure. The stent-graft
was positioned across the aneurysm with the
aid of radiopaque markers on the carrier cath-
eter and the external sheath. The device was
deployed by trigger retrieval of the external
sheath while maintaining the carrier cathe-
ter’s position. A 750-mg bolus of cefamandole
was administered intravenously at the end of
the procedure.
One covered stent was implanted in each
animal except the first one, in which 2 devices
were deployed in overlapping fashion in an
attempt to immediately exclude the aneu-
rysm. After deployment of the covered stent,
digital subtraction angiography (DSA) of the
aorta was performed using pump injection of
20 mL of ioxaglate (320 mg iodine/mL) at a
flow rate of 10 mL/s. Both anteroposterior and
lateral views were obtained at an acquisition
rate of 4 images per second.
Surveillance Imaging
Animals were examined with spiral com-
puted tomography (CT) under anesthesia (in-
tramuscular injections of acepromazine ace-
tate [1 mL/10 kg] and ketamine [500 mg]) at 1
month and with angiography at 3 and 6
months, depending on the sacrifice date. Ev-
ery sacrificed animal underwent DSA before
euthanasia. Spiral CT scanning (Somatom
Plus 4 CT scanner, Siemens AG, Forchheim,
Germany) was performed with 5-mm colli-
mation, pitch 5 1, and a reconstruction incre-
ment of 2.5 mm. Images were acquired before
and after intravenous injection of ioxitalamate
meglumine (30 g iodine/100 mL) at a dose of
2.5 mL/kg. Postcontrast data were also pro-
cessed to obtain 3-dimensional views in max-
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Figure 3lLevels of aortic sampling for pathologic
examination: A and H, aortic wall only; B and G,
junction zones (stent only); C and F, intermediate
zones (nitinol stent and polyester covering); D and
E, upper and lower aneurysm zones (15 mm from
surgical anastomoses).
imum intensity projections and multiplanar
reconstructions.
No pressure measurements in the aneu-
rysm sac were taken in this experiment. To
monitor aneurysm sac behavior, dimensions
of the aneurysm sac and the aortic blood flow
column were recorded at baseline and serially
compared during follow-up using a common
distance ratio, R, to consistently relate these
measurements over time, across individual
animals, and between imaging modalities. R
was the ratio of the maximal diameter of the
aneurysm sac in the transverse horizontal
plane to the diameter of the blood flow col-
umn in the aorta at the same level. In addition
to being dimensionless and independent of
magnification errors, this ratio was believed
to reduce intermodality variability in mea-
surement and provide a meaningful compar-
ison among angiography, CT, and pathology.
Pathological Analysis
Specimens from all animals were retrieved
and examined. Animals surviving to the end
of their scheduled implantation period under-
went angiography under anesthesia (intra-
muscular injection of ketamine [500 mg]). Af-
ter intravenous injection of 1,000 units of
heparin, the animal was sacrificed by an in-
travenous injection of 2 mL of T-61 (Hoechst,
Paris, France), a muscular paralytic agent con-
taining a local and general anesthetic agent
that produced immediate death. The aorta
was then removed en bloc from the suprare-
nal portion to the aortoiliac bifurcation,
washed with saline, and immersed in a 10%
neutral buffered formalin solution.
After 24 to 48 hours of fixation, the aortic
specimen was opened longitudinally. The en-
doluminal surface of the aorta was examined
visually before 1-mm samples were taken at
8 levels, as shown in Figure 3. The metallic
struts were removed with a tweezers. After
dehydration with alcohol and acetone, the
specimens were embedded in paraffin and
sectioned into 5-mm slices for staining with
hematoxylin-eosin, Masson trichrome (for
collagen fibers), and Verhoeff’s ferric iodinat-
ed hematoxylin (for elastic fibers). Microscop-
ic examination was performed using a light
microscope.
For surface analysis, a quantitative histo-
morphometric study was performed on the
basis of the digitalized images obtained from
magnified views of the specimens. Thickness
assessments of the aortic intima, neointima,
and media (Fig. 4) were made using a dedi-
cated software package (NIH Image, Macin-
tosh, Apple Computer, Inc., Cupertino, CA,
USA). A mean value was averaged from 3
measures obtained at each level studied.
In each animal, an average of 4 samples
from inside and outside the aneurysm zone
were prepared for scanning electron micros-
copy. After fixation in formaldehyde and os-
mium tetroxide, samples were dehydrated in
a graded alcohol series (50–100%) and sput-
ter-coated with a mixture of gold and plati-
num (50-nm layer).
Definitions and Statistical Analysis
According to the guidelines of the Society
for Vascular Surgery/ International Society for
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Figure 4lTissue section from an aneurysm zone stained with Masson trichrome (34), illus-
trating the quantitative computer-assisted method of assessing the thickness of the neointima
(NI) and media (M). The hole (B) was the site of a metallic strut, which had been removed.
Cardiovascular Surgery and the Society for
Cardiovascular Interventional Radiology,3
stent-grafts were assessed for safety and ef-
ficacy based on the following criteria: (1) com-
plete aneurysm exclusion, (2) absence of ex-
pansion and rupture of the excluded
aneurysm, (3) patency of the covered stent lu-
men, and (4) no device migration, infection,
perforation, or hematoma.
Results are expressed as mean 6 SD.
Group comparisons of continuous data were
analyzed with nonparametric paired and non-
paired Student t tests using a 5 0.05 (p ,
0.05).
RESULTS
Experimental model
The aneurysms were created in the 20 sheep
during a mean 21-minute clamp time (range
15–30) in native aortas measuring 7.2 6 0.4
mm (range 6.4–8.4) in diameter. The mean
length of the surgically created aneurysm was
32.8 6 7.5 mm (range 22.6–53) and the mean
internal diameter was 11.8 6 1.7 mm (range
8.7 6 14.4). The average baseline R ratio was
1.58 6 0.23 (range 1.20–1.89).
Seven (35%) animals died within 24 hours,
3 of suspected heparin overdose (retroperi-
toneal hemorrhage without intimal or anas-
tomotic rupture) and 1 owing to hypoxemia
related to a mucous plug in the endotracheal
tube. The cause of death in the other 3 ani-
mals remained unclear but might have been
related to the rapid infusion of the cold med-
ullary protection solution. Another (5%) ani-
mal presented with postoperative paraplegia
and an aneurysmal thrombosis; it was sacri-
ficed at day 1.
Three animals died of aneurysm rupture at
6, 8, and 9 days (mean 7.7 6 1.5). In the 9
surviving sheep, the mean R ratio increased
between preimplantation (1.57 6 0.28) and
follow-up at 3 months (1.63 6 0.43), but the
difference was not significant (t 5 0.771, p ,
0.46). The mean R ratios did not differ be-
tween the AAA control group and the 6 ani-
mals in which the stent-grafts were implanted
at 3 months. The 3 sheep in the AAA control
group were sacrificed at 3, 6, and 9 months
after AAA creation.
Over a follow-up period that extended to
280 days (mean 85.6 6 75.0), no death, local
or general complication, or secondary device
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Figure 5lA contrast-enhanced spiral CT scan 1
month after stent-grafting showing the metallic
struts surrounding the patent lumen of the stent-
graft with complete aneurysm exclusion; there is
no evidence of a perigraft leak.
Figure 6lDigital subtraction arteriogram 3
months after stent-grafting in the animal shown in
Figure 2. Note the regular, patent aortic lumen and
absence of endoleak.
migration was observed in the 6 stent-grafted
animals. Immediate arteriographic controls
showed both the absence of complete aneu-
rysmal exclusion and the presence of slow
flow in the aneurysm sac in all 6 cases. How-
ever, the aneurysm sacs were always exclud-
ed on the 1-month CT (Fig. 5) and on later
angiograms (Fig. 6). The lumen of the device
was patent on all imaging studies. In 1 ani-
mal, the arteriogram at 3 months showed
small irregularities along the covered portion,
but these completely disappeared at 6
months.
In the 6 stent-grafted sheep (Table), the
slight decrease in the mean R ratio observed
between preimplantation and on-table post-
implantation measurements was not signifi-
cant (p , 0.16). On the other hand, there was
a statistically significant reduction in mean R
ratio between preimplantation and measure-
ments at both 1 month (p , 0.034) and the
end of the study (p , 0.034).
Histopathological Study
On gross examination, all aortic specimens
except those from the 8 early autopsies were
surrounded by highly adherent retroperito-
neal tissue. The 3 ruptured aneurysms each
had a 1- to 2-cm-long tear in the venous wall
at some distance from both anastomoses.
The 3 control aneurysms demonstrated a reg-
ular, thin aortic wall up- and downstream
from the AAA. There was a slight parietal
thickening at anastomotic sites, and the an-
eurysm wall was thick, regular, and fully cov-
ered with neointima (including the valvular
remnants). No thrombus or fibrin deposits
were present in the aneurysm lumen at nec-
ropsy.
In the 6 stent-grafted animals, the nonstent-
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TABLE
Follow-up in 6 Animals Receiving Stent-Grafts 3
Months After AAA Creation
Time Interval R Ratio
Before implantation
Postimplantation (completion
angiography)
At 1-month follow-up CT
At sacrifice
1.78 6 0.46
1.51 6 0.16
1.34 6 0.16*
1.33 6 0.15*
l l
* Significant difference from baseline (t 5 2.87, p ,
0.034) by Student t test.
Figure 7lPhotograph of an explanted specimen.
The metallic stent is covered by neointima, which
appears thicker at junction zones (upper portion)
than at the aneurysm level (lower portion). The an-
eurysm sac is collapsed and closely adherent to
the stent-graft.
ed portions of the aorta were normal. A renal
artery in 1 animal and 1 lumbar artery in 2
animals were covered by stent struts and re-
mained fully patent. The aneurysm sac ad-
hered closely to the stent, and exclusion was
confirmed in each case.
Junction zones (i.e., segments crossed by
the bare portion of the stent) were covered by
a thick, regular neointima without narrowing
(Fig. 7), except in 1 case with 20% stenosis of
the lower inferior junction. At the level of the
junction zones, 3 different patterns were ob-
served: (a) absence of neointima, (b) multifo-
cal, small, central neointimal islets, or (c) full
neoendothelialization of the stent. There was
no clear relation between the pattern ob-
served and the duration of device implanta-
tion. The nonendothelialized areas were ei-
ther fibrinous and regular or fibrinocruoric,
irregular, and mixed with small cells. Fibri-
nocruoric deposits were found in 5 of 6 ani-
mals in both nonendothelialized and endothe-
lialized zones.
Under light microscopy, the nonstented
portions of the aorta appeared normal in the
stent-graft group. Junction zones were char-
acterized by increased fibrosis. The intima
was thick and fibrocellular; the media was
thin, fibrous, and deviated by the metallic
struts but without rupture of the elastic lami-
nae.
In the aneurysm sac, large variations were
noted depending on the level studied regard-
less of the follow-up duration. No inflamma-
tion was seen. Endothelialization was focal
only. The neointima was of a highly variable
thickness and contained some smooth mus-
cle cells. The metallic endoprosthesis was
surrounded by a loose connective tissue
(myofibroblasts, collagen fibers, a few elastic
fibers), neovessels, and giant cells.
The polyester covering appeared undulated
on axial slices and sometimes very superfi-
cial, even slightly protruding into the lumen
like an ulcer. A loose connective tissue was
observed between the polyester fibrils. The
aneurysm sac was collapsed and contained
exceptionally scarce thrombi. The venous
wall structure was difficult to identify owing
to a thin and fully fibrous venous media and
a thick and highly vascularized adventitia. No
cleavage plan was found.
A quantitative surface analysis was made at
the level of zones A, B, G, and H (Fig. 3) of
the 6 implanted animals and on the aneurys-
mal neointima and the normal upper and low-
er aortic portions of the 3 controls. No statis-
tically significant difference in the mean
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Figure 8lA series of scanning electron photomicrographs from an explanted specimen. Note
the folded appearance of the polyester fabric, which pushes the thin nonendothelialized neo-
intima toward the lumen in the upper left scan (3100). The upper right image (3200) is an
endoluminal view at the level of the stent-graft, showing good endothelialization. A few
threads of polyester are protruding in the lumen. The lower left image (3100) shows the
polyester well integrated in the wall around a metallic strut that had been removed. In the
lower right scan (3500), polyester filaments covered by blood cells protrude into the lumen.
intimomedial thickness was found between
the upper and lower unstented aortic seg-
ments (A and H) or between stent-grafted
sheep and the controls (paired series). There
was also no difference in intimomedial thick-
ness between the upper and lower junction
zones (B and G) in stented animals (paired se-
ries). The 3 control animals had a highly var-
iable neointimal thickness at the level of the
aneurysm sac, which appeared unrelated to
AAA duration.
Scanning electron microscopy confirmed
the light microscopy data by visualizing en-
dothelialized areas and integration of the me-
tallic structure and the polyester in the aortic
wall at the different levels (Fig. 8).
DISCUSSION
Several animal models of aneurysmal ab-
dominal aorta are available,4–13 but none of
them can currently be considered as the ideal
reference standard. To be an accurate model,
the aorta must be of approximately the same
size as in a human being to study the devices
under comparable situations. However,
weight and cost are significant factors influ-
encing the choice of the animal. Experimental
studies on healthy arteries are useful only to
study the technical (implantation) and biolog-
ical (biocompatibility) characteristics of the
endoprostheses. Aortic dilation by a balloon
catheter results in a limited increase in lumi-
nal diameter only. Neither healthy nor dilated
aortic models evolve toward arterial rupture;
however, elastase-based models8,9 seem to
better match the actual pathophysiology of
natural human AAAs. They are, however,
technically difficult to create (especially in
large animals), and their results are unpre-
dictable.
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Several materials have been used to re-
place an aortic segment by a more easily ex-
pandable component. Polyester patches or in-
terposition grafts5,11,12 do not mimic the true
evolution of AAAs. Heterologous (e.g., bovine
jugular vein in a pig4) and autologous (e.g.,
fascia of rectus abdominis muscles13) mate-
rials do not result in aortic rupture, except for
the jejunum patch,7 which invariably leads to
spontaneous perforation within a few days
(i.e., too early). However, Bougdhe`ne et al.1
have described a model that seems very at-
tractive because it uses autologous material,
looks quite similar to human pathophysiolo-
gy, and is associated with a significant risk of
rupture under arterial pressure. Their experi-
mental AAA model, which used a left internal
jugular vein segment anastomosed end-to-
end to the divided infrarenal abdominal aorta
of sheep, resulted in rupture in all animals
within ,4 months. We used the same model
in our study owing to its progressive natural
dilatation; however, the rate of spontaneous
aneurysm rupture at 3 months was only 25%
in our series, and the R ratio did not show a
significant increase in aneurysm size over the
3 months following AAA creation.
There were other limitations with this ex-
perimental model, notably, the absence of
backflow supply from collaterals into the an-
eurysm sac. Retrograde flow from lumbar or
inferior mesenteric arteries is now well rec-
ognized as a factor in endoleaks and perhaps
also late ruptures. Moreover, this model can
have a high rate of paraplegia, but we en-
countered this problem in only 1 of our ani-
mals. We believe this was due to our im-
proved technique after we became familiar
with the procedure, which reduced operative
time and avoided aortic thrombosis and sub-
sequent spinal ischemia in our last 6 animals.
However, there may be other means of avoid-
ing paraplegia in these models. Beygui et al.10
described an interesting maneuver to prevent
spinal ischemia during AAA creation in an
ovine model using an internal shunt and an
internal iliac-to-external iliac transposition.
Owing to these deficiencies in current mod-
els, we are continuing to develop a new ex-
perimental AAA based on Bougdhe`ne’s work
but altering the approach to spare the collat-
eral aortic branches. Design of this model in-
cludes surgical placement of a longitudinal
autologous venous patch on the anterior wall
of the abdominal aorta. In this model, the su-
ture plane is coronal and not transverse, and
the initial diameter of the AAA is higher. We
hope that this model will allow a more reli-
able rupture rate with better reproducibility.
Stent-grafts are now available in a wide
choice of materials for both the metallic frame
and the textile covering. Synthetic fabrics cur-
rently used include thin woven polyester,
polytetrafluoroethylene, and polyurethane.11
They are advantageous because of their de-
cades-long use and well known physical
properties. However, the rigidity and size of
devices made with these materials makes
them poorly suited to percutaneous delivery.
Another concept of aneurysm exclusion
uses macroporous endoprostheses. Even bare
metallic stents have been proposed14; their
close mesh allows delivery via smaller intro-
ducer systems on the one hand, and, in theory,
preserved patency of the visceral arteries ad-
jacent to the implantation zone on the other
hand. Among covered stents, a tantalum–Da-
cron coknit balloon-expandable device gave
good results in both in vivo and clinical use.12
The device we used combined the high flex-
ibility, maneuverability, and shape-memory
advantages of nitinol with a low profile intro-
ducer system made possible by the macro-
porous polyester. The fact that this device is
constructed at the time of use and not com-
mercially manufactured is a definite asset, as
several cost-effectiveness studies have
shown that the financial benefit of reduced
hospital stays achieved with endovascular
treatment is countered to a significant degree
by the cost of manufactured stent-grafts.15–17
The weak point of this covered stent design
is obviously the covering, which does not im-
mediately exclude the aneurysm, so postim-
plantation assessment in the operating room
would not be possible. Although leaks may
still be treated by balloon dilation, stent-graft
extension, or even embolization in secondary
procedures, many teams now choose to treat
primary endoleaks before the procedure is
completed.
Typically, major leaks lead to aortic rupture
and necessitate aggressive management. In
minor leaks, the consequences on sac pres-
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sure are not well known, and therapeutic
management is subject to discussion. More-
over, no clear-cut limit exists to delineate
these two degrees of severity. The experi-
mental study of Marty et al.18 is interesting
with respect to this problem. Complete exclu-
sion significantly lowers the pressure in the
aneurysm sac. In animals where a prerupture
of the endoprosthesis can be shown, the im-
portance of the leak is highly variable (mainly
depending on individual factors, particularly
the coagulation system), but whatever the im-
portance of the leak, the pressure in the sac
is always significantly elevated. This confirms
that any leak should be closely followed and
sometimes aggressively treated.
Furthermore, aneurysmal expansion, and
even aortic rupture, have also been observed
in the absence of any demonstrable leak.19,20
Explanations for this phenomenon include (1)
the supposed ineffectiveness of imaging
methods to show some leaks and (2) the per-
sistent transmission of aortic pressure into
the sac despite delayed thrombosis of any
leak. For instance, the use of coils may result
in thrombosis of the sac and aneurysmal ex-
clusion without significant reduction of intra-
sac pressure. Although we did not measure
pressure in the sac, the endograft we tested
did eventually exclude the aneurysm despite
the macroporous fabric. Furthermore, the de-
crease in aneurysm diameter was constant in
all animals, which argues in favor of an effec-
tive exclusion from the blood flow.
In conclusion, this study showed the limits
of a previously described experimental AAA
model using autologous venous segmental
grafting of the infrarenal aorta. Although the
model has some similarities with human
pathophysiology, timing and reproducibility
of aneurysm rupture can be improved. Im-
plantation of the macroporous covered stent
was feasible and easy, but some modification
may be necessary to shorten the delay in ob-
taining aneurysm exclusion.
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